Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy
Carly Bess Scalise(Medical University of South Carolina), Ann Richmond(Vanderbilt University), Caroline A. Nebhan(VA Tennessee Valley Healthcare System), Sheau‐Chiann Chen(Vanderbilt University Medical Center), Anna E. Vilgelm(The Ohio State University), Ingrid A. Mayer(Vanderbilt University), Vandana G. Abramson(Vanderbilt University), Lauren S. Starnes(Vanderbilt University Medical Center), Chi Yan(Zhengzhou University), Jinming Yang(University of Kentucky), Gregory D. Ayers(Vanderbilt University)
Cited by 6
Related Papers
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
|Cancer Cell|2008|917
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
|New England Journal of Medicine|2019|846
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy
|Nature Communications|2016|572
Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy
|npj Breast Cancer|2016|446